|
1
|
Fedullo PF, Kerr KM, Auger WR, Jamieson SW
and Kapelanski DP: Chronic thromboembolic pulmonary hypertension.
Semin Respir Crit Care Med. 21:563–574. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moser KM, Daily PO, Peterson K, Dembitsky
W, Vapnek JM, Shure D, Utley J and Archibald C:
Thromboendarterectomy for chronic, major vessel thromboembolic
pulmonary hypertension: immediate and long-term results in 42
patients. Ann Intern Med. 107:560–565. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jamieson SW, Kapelanski DP, Sakakibara N,
Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF and
Auger WR: Pulmonary endarterectomy: experience and lessons learned
in 1,500 cases. Ann Thorac Surg. 76:1457–1464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maruoka M, Sakao S, Kantake M, Tanabe N,
Kasahara Y, Kurosu K, Takiguchi Y, Masuda M, Yoshino I, Voelkel NF
and Tatsumi K: Characterization of myofibroblasts in chronic
thromboembolic pulmonary hypertension. Int J Cardiol. Mar 14–2011,
(Epub ahead of print).
|
|
5
|
Yao W, Firth AL, Sacks RS, Ogawa A, Auger
WR, Fedullo PF, Madani MM, Lin GY, Sakakibara N, Thistlethwaite PA,
Jamieson SW, Rubin LJ and Yuan JX: Identification of putative
endothelial progenitor cells
(CD34+CD133+Flk-1+) in
endarterectomized tissue of patients with chronic thromboembolic
pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol.
296:L870–L878. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Firth AL, Yao W, Ogawa A, Madani MM, Lin
GY and Yuan JX: Multipotent mesenchymal progenitor cells are
present in endarterectomized tissues from patients with chronic
thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol.
298:C1217–C1225. 2010. View Article : Google Scholar
|
|
7
|
Sakao S, Hao H, Tanabe N, Kasahara Y,
Kurosu K and Tatsumi K: Endothelial-like cells in chronic
thromboembolic pulmonary hypertension: crosstalk with
myofibroblast-like cells. Respir Res. 12:1092011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bloomberg RD, Butany JW, Cusimano RJ and
Leask RL: Primary cardiac sarcoma involving the pulmonary artery
and valve. Can J Cardiol. 19:843–847. 2003.PubMed/NCBI
|
|
9
|
Bode-Lesniewska B, Zhao J, Speel EJ,
Biraima AM, Turina M, Komminoth P and Heitz PU: Gains of 12q13–14
and overexpression of mdm2 are frequent findings in intimal
sarcomas of the pulmonary artery. Virchows Arch. 438:57–65.
2001.
|
|
10
|
Gaumann A, Petrow P, Mentzel T, Mayer E,
Dahm M, Otto M, Kirkpatrick CJ and Kriegsmann J: Osteopontin
expression in primary sarcomas of the pulmonary artery. Virchows
Arch. 439:668–674. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burke AP and Virmani R: Sarcomas of the
great vessels. Cancer. 71:1761–1773. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McGlennen RC, Manivel JC, Stanley SJ,
Slater DL, Wick MR and Dehner LP: Pulmonary artery trunk sarcoma: a
clinicopathologic, ultrastructural, and immunohistochemical study
of four cases. Mod Pathol. 2:486–494. 1989.PubMed/NCBI
|
|
13
|
Hanahan D and Weinberg R: The hallmarks of
cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
14
|
Rai PR, Cool CD, King JA, Stevens T, Burns
N, Winn RA, Kasper M and Voelkel NF: The cancer paradigm of severe
angioproliferative pulmonary hypertension. Am J Respir Crit Care
Med. 178:558–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakao S and Tatsumi K: Vascular remodeling
in pulmonary arterial hypertension: multiple cancer-like pathways
and possible treatment modalities. Int J Cardiol. 147:4–12. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Loebinger MR, Sage EK and Janes SM:
Mesenchymal stem cells as vectors for lung disease. Proc Am Thorac
Soc. 5:711–716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aguilar S, Nye E, Chan J, Loebinger M,
Spencer-Dene B, Fisk N, Stamp G, Bonnet D and Janes SM: Murine but
not human mesenchymal stem cells generate osteosarcoma-like lesions
in the lung. Stem Cells. 25:1586–1594. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu J, Fujibayashi A, Yamada KM and
Sekiguchi K: Laminin-10/11 and fibronectin differentially prevent
apoptosis induced by serum removal via phosphatidylinositol
3-kinase/Akt- and MEK1/ERK-dependent pathways. J Biol Chem.
277:19922–19928. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Adachi Y, Yamamoto H, Itoh F, Hinoda Y,
Okada Y and Imai K: Contribution of matrilysin (MMP-7) to the
metastatic pathway of human colorectal cancers. Gut. 45:252–258.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto H, Iku S, Adachi Y, Imsumran A,
Taniguchi H, Nosho K, Min Y, Horiuchi S, Yoshida M, Itoh F and Imai
K: Association of trypsin expression with tumour progression and
matrilysin expression in human colorectal cancer. J Pathol.
199:176–184. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bolon I, Devouassoux M, Robert C, Moro D,
Brambilla C and Brambilla E: Expression of urokinase-type
plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin
genes in lung carcinomas. Am J Pathol. 150:1619–1629.
1997.PubMed/NCBI
|
|
22
|
Heppner KJ, Matrisian LM, Jensen RA and
Rodgers WH: Expression of most matrix metalloproteinase family
members in breast cancer represents a tumor-induced host response.
Am J Pathol. 149:273–282. 1996.PubMed/NCBI
|
|
23
|
Yamamoto H, Adachi Y, Itoh F, Iku S,
Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M and
Imai K: Association of matrilysin expression with recurrence and
poor prognosis in human esophageal squamous cell carcinoma. Cancer
Res. 59:3313–3316. 1999.PubMed/NCBI
|
